Marc James joins Solésence (Nasdaq: SLSN) board and key committees
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Solésence, Inc. announced that its Board of Directors appointed Marc James as a Class II independent director, effective April 24, 2026. He will serve for the remainder of the Class II term, ending at the 2026 Annual Meeting of Shareholders.
James joins the Board’s Audit and Finance, Compensation, and Nominating and Corporate Governance Committees. The company highlights his capital markets and strategic experience as support for its Transform & Transcend strategic initiative and long-term growth objectives.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.02, 9.01
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Director appointment effective date: April 24, 2026
Director term end: 2026 Annual Meeting of Shareholders
Press release date: April 27, 2026
3 metrics
Director appointment effective date
April 24, 2026
Effective date of Marc James joining the Solésence Board
Director term end
2026 Annual Meeting of Shareholders
Expiration of current Class II director term
Press release date
April 27, 2026
Date of Exhibit 99.1 announcing the appointment
Key Terms
independent director, Audit and Finance Committee, Compensation Committee, Nominating and Corporate Governance Committee, +2 more
6 terms
independent director financial
"announced the appointment of Marc James to its Board of Directors as an independent director"
An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.
Audit and Finance Committee financial
"Mr. James has been appointed to the following committees of the Board: Audit and Finance Committee"
A board-level group charged with overseeing a company’s financial reporting, internal checks and balances, audit processes and relationship with external auditors. Think of them as a trusted inspector and bookkeeper who verify that the company’s accounts are accurate, legal and transparent; their work matters to investors because strong oversight reduces the risk of errors or fraud, builds confidence in reported results and can affect valuation and access to capital.
Compensation Committee financial
"Mr. James has been appointed to the following committees of the Board: Audit and Finance Committee, Compensation Committee"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
Nominating and Corporate Governance Committee financial
"Mr. James has been appointed to the following committees of the Board: Audit and Finance Committee, Compensation Committee, and Nominating and Corporate Governance Committee"
A nominating and corporate governance committee is a group within a company's board of directors responsible for selecting and recommending individuals to serve as company leaders, such as directors or executives. They also develop and oversee policies to ensure the company is run fairly, ethically, and transparently. This committee matters to investors because it helps ensure the company is well-managed and guided by qualified, responsible leadership.
forward-looking statements regulatory
"This press release contains words such as “expects,” “shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Private Securities Litigation Reform Act of 1995 regulatory
"forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995"
FAQ
What does Solésence (SLSN) announce in this 8-K filing?
Solésence announces the appointment of Marc James as a Class II independent director, effective April 24, 2026. He will serve on the Audit and Finance, Compensation, and Nominating and Corporate Governance Committees, supporting governance as the company pursues its Transform & Transcend growth initiative.
Who is Marc James, the new independent director at Solésence (SLSN)?
Marc James is an experienced executive with a background in global financial markets and capital markets advisory. He has held senior managing director roles focused on capital markets activities, interest rate risk management, financing strategies, and governance, aligning with Solésence’s strategic growth and board expertise needs.
How long will Marc James serve on the Solésence (SLSN) board?
Marc James will serve as a Class II director for the remainder of the current term, which expires at the 2026 Annual Meeting of Shareholders. His role begins effective April 24, 2026, aligning his tenure with the existing Class II directorship cycle.
Which board committees will Marc James join at Solésence (SLSN)?
Marc James will serve on three key board committees: the Audit and Finance Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee. These assignments position him within core oversight areas for financial reporting, executive pay, and board composition and governance practices.
How does Solésence (SLSN) describe its strategy around this board appointment?
Solésence links Marc James’s appointment to its focus on strong corporate governance and enhanced board expertise. The company references its Transform & Transcend strategic initiative and long-term growth objectives, suggesting his capital markets and strategic background complements its efforts to scale operations and expand brand partnerships.
What business focus does Solésence (SLSN) highlight in the press release?
Solésence highlights its role in scientifically-driven health care solutions across beauty and life science categories. It emphasizes redefined mineral-based sun protection, integrating protection, prevention, and treatment technologies into daily-use products, enabling partner brands to offer differentiated skin health and cosmetic performance claims to consumers.